Unknown

Dataset Information

0

A rare human sequence variant reveals myocardin autoinhibition.


ABSTRACT: Myocardin (MYOCD) is a transcriptional co-activator that promotes cardiac or smooth muscle gene programs through its interaction with myocyte-enhancing factor (MEF2) or serum-response factor (SRF). Isoforms of MYOCD with a truncated amino terminus show increased activity when compared with those with the full-length amino terminus, but how this is achieved remains unknown. We identified a rare human sequence variation in MYOCD in a patient with congenital heart disease that resulted in a missense mutation at codon 259 (K259R). This variation created a hypomorphic cardiac isoform with impaired SRF binding and transactivation capacity but did not impair the smooth muscle isoform of MYOCD, which lacks the amino terminus. Consistent with differential effects of the amino terminus on the K259R mutation, we found that the cardiac-specific amino terminus acted in an autoinhibitory fashion to bind MYOCD via specific negatively charged residues and thereby repressed SRF-dependent MYOCD activity. This effect was exaggerated in the MYOCD-K259R mutant. The amino terminus was sufficient to impair MYOCD-dependent fibroblast conversion into smooth muscle cells as well as cardiomyocyte hypertrophy. These findings identify a novel mechanism that regulates levels of MYOCD-dependent activation of the SRF genetic program differentially in cardiac and smooth muscle.

SUBMITTER: Ransom JF 

PROVIDER: S-EPMC2602885 | biostudies-literature | 2008 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

A rare human sequence variant reveals myocardin autoinhibition.

Ransom Joshua F JF   King Isabelle N IN   Garg Vidu V   Srivastava Deepak D  

The Journal of biological chemistry 20081013 51


Myocardin (MYOCD) is a transcriptional co-activator that promotes cardiac or smooth muscle gene programs through its interaction with myocyte-enhancing factor (MEF2) or serum-response factor (SRF). Isoforms of MYOCD with a truncated amino terminus show increased activity when compared with those with the full-length amino terminus, but how this is achieved remains unknown. We identified a rare human sequence variation in MYOCD in a patient with congenital heart disease that resulted in a missens  ...[more]

Similar Datasets

| S-EPMC6537421 | biostudies-literature
| S-EPMC7205561 | biostudies-literature
| S-EPMC2978957 | biostudies-literature
| S-EPMC5310914 | biostudies-literature
| S-EPMC8282602 | biostudies-literature
| S-EPMC3135811 | biostudies-literature
| S-EPMC5520073 | biostudies-literature
| S-EPMC8463695 | biostudies-literature
| S-EPMC6856716 | biostudies-literature
| S-EPMC7229597 | biostudies-literature